Clinically used JAK inhibitor blunts dsRNA‐induced inflammation and calcification in aortic valve interstitial cells

Volume: 288, Issue: 22, Pages: 6528 - 6542
Published: Jun 25, 2021
Abstract
Calcific aortic valve disease (CAVD) is the most prevalent valvulopathy worldwide. Growing evidence supports a role for viral and cell‐derived double‐stranded (ds)‐RNA in cardiovascular pathophysiology. Poly(I:C), a dsRNA surrogate, has been shown to induce inflammation, type I interferon (IFN) responses, and osteogenesis through Toll‐like receptor 3 in aortic valve interstitial cells (VIC). Here, we aimed to determine whether IFN signaling via...
Paper Details
Title
Clinically used JAK inhibitor blunts dsRNA‐induced inflammation and calcification in aortic valve interstitial cells
Published Date
Jun 25, 2021
Volume
288
Issue
22
Pages
6528 - 6542
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.